Skip to content

Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases

Document Type
Publications · Review Article
Registered DB
SCIEScopus
Journal Ranking
JCR Q1Scopus Q1
Journal
ADVANCED DRUG DELIVERY REVIEWS176 · #113887 · 2021
Citation
Web of Science 191Scopus 205
FWCI (Scopus)
3.23
JCR IF
JCR 2020 15.47
ISSN
0169-409X

Authors

  1. Zu, MenghangFirst authorSouthwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China
  2. Ma, YaSouthwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China
  3. Cannup, BrandonGeorgia State Univ, Inst Biomed Sci, Digest Dis Res Grp, Atlanta, GA 30302 USA
  4. Xie, DengchaoSouthwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China
  5. Jung, YunjinPusan Natl Univ, Coll Pharm, Busan 46241, South Korea
  6. Zhang, JinmingChengdu Univ Tradit Chinese Med, Sch Pharm, State Key Lab Southwestern Chinese Med Resources, Chengdu 611137, Sichuan, Peoples R China
  7. Yang, ChunhuaGeorgia State Univ, Inst Biomed Sci, Digest Dis Res Grp, Atlanta, GA 30302 USA
  8. Gao, FeiCorresponding authorChengdu Univ Tradit Chinese Med, Sch Pharm, State Key Lab Southwestern Chinese Med Resources, Chengdu 611137, Sichuan, Peoples R China
  9. Merlin, DidierCorresponding authorGeorgia State Univ, Inst Biomed Sci, Digest Dis Res Grp, Atlanta, GA 30302 USA
  10. Xiao, BoCorresponding authorSouthwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China

Abstract

The incidence of inflammatory bowel disease (IBD) is rapidly rising throughout the world. Although tremendous efforts have been made, limited therapeutics are available for IBD management. Natural active small molecules (NASMs), which are a gift of nature to humanity, have been widely used in the prevention and alleviation of IBD; they have numerous advantageous features, including excellent biocompatibility, pharmacological activity, and mass production potential. Oral route is the most common and acceptable approach for drug administration, but the clinical application of NASMs in IBD treatment via oral route has been seriously restricted by their inherent limitations such as high hydrophobicity, instability, and poor bioavailability. With the development of nanotechnology, polymeric nanoparticles (NPs) have provided a promising platform that can efficiently encapsulate versatile NASMs, overcome multiple drug delivery barriers, and orally deliver the loaded NASMs to targeted tissues or cells while enhancing their stability and bioavailability. Thus, NPs can enhance the preventive and therapeutic effects of NASMs against IBD. Herein, we summarize the recent knowledge about polymeric matrix based carriers, targeting ligands for drug delivery, and NASMs. We also discuss the current challenges and future developmental directions. (c) 2021 Elsevier B.V. All rights reserved.

Keywords

Inflammatory bowel diseaseOral administrationPolymeric nanoparticleTargeting ligandNatural active small moleculeSILK FIBROIN NANOPARTICLESPH-SENSITIVE NANOPARTICLESCOLON-TARGETED DELIVERYINDUCED EXPERIMENTAL COLITISDRUG-DELIVERYULCERATIVE-COLITISDOUBLE-BLINDIN-VITROBIODEGRADABLE NANOPARTICLESMACROMOLECULAR PRODRUGS

Identifiers

Scopus EID
2-s2.0-85111581819
WoS UID
000697164900010